Strata Critical Medical, Inc. Class A Common Stock SRTA Business Segments
| TTM Q1 '25 | ||
|---|---|---|
| Revenue by Business | ||
| Clinical | $0— | |
| Logistics | $146.06M-0.5% | |
| Gross Profit by Business | ||
| Clinical | $0— | |
| Logistics | $29.24M-1.2% | |
| Cost of revenue by Business | ||
| Clinical | $0— | |
| Logistics | $116.82M-0.4% | |
| Revenue by Product | ||
| Other Clinical | $0— | |
| Transplant Clinical | $0— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Strata Critical Medical, Inc. Class A Common Stock break its business down?
- Strata Critical Medical, Inc. Class A Common Stock (SRTA) reports revenue by business across 2 parts — Clinical and Logistics. Each is extracted from the segment footnotes and tracked over time.
- Where does Strata Critical Medical, Inc. Class A Common Stock's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Strata Critical Medical, Inc. Class A Common Stock's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
